This companion document to Ending the neglect to attain the Sustainable Development Goals: a road map for neglected tropical diseases 2021-2030 (“the road map”) aims to support a range of stakeholders – including countries in which neglected tropical diseases (NTDs) are endemic, international organizations and non-State actors – to achieve the road map targets through a transdisciplinary, cross-cutting One Health approach. The document has six sections.

Financing the acceleration of the progress needed to reach the 2030 targets was highlighted throughout the global consultation on which the NTD road map 2021-2030 was based. For some time, a lack of resources has been seen as a significant barrier to control, elimination and eradication. This challenge has only been intensified by the COVID-19 pandemic; indeed, the pandemic has altered the course of many public health objectives for the near and long terms alike. In response to the need to raise the funding and resources highlighted by the global neglected tropical disease community, the World Health Organization prepared this rationale for global investment as an advocacy document to support and augment the implementation of the road map. This rationale was developed in an already complex funding landscape and in the context of a wide-ranging and diverse set of diseases. It was also prepared against a background of unprecedented cuts to aid budgets and shifting international priorities. This document sets out, therefore, to explain the socioeconomic value of investing in the fight against neglected tropical diseases and highlights priorities for global investment attention. Our work was guided by the need not only for additional funding and funders but also for the need to understand the current funding climate, in which value for money and the efficient use of resources to fill the most critical of gaps are more relevant than ever.

Infectious diseases are the leading cause of death globally, particularly among children and young adults. The spread of new pathogens and the threat of antimicrobial resistance pose particular challenges in combating these diseases. Major Infectious Diseases identifies feasible, cost-effective packages of interventions and strategies across delivery platforms to prevent and treat HIV/AIDS, other sexually transmitted infections, tuberculosis, malaria, adult febrile illness, viral hepatitis, and neglected tropical diseases. The volume emphasizes the need to effectively address emerging antimicrobial resistance, strengthen health systems, and increase access to care. The attainable goals are to reduce incidence, develop innovative approaches, and optimize existing tools in resource-constrained settings.

A global assessment of potential and anticipated impacts of efforts to achieve the SDGs on forests and related socio-economic systems. This title is available as Open Access via Cambridge Core.